Farther Finance Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$462K Buy
25,420
+4,088
+19% +$72.4K ﹤0.01% 1646
2026
Q2
$342K Buy
21,332
+3,504
+20% +$58K ﹤0.01% 1852
2026
Q1
$335K Buy
17,828
+7,959
+81% +$140K ﹤0.01% 1675
2025
Q4
$154K Buy
9,869
+2,868
+41% +$41K ﹤0.01% 2079
2025
Q3
$102K Buy
7,001
+1,378
+25% +$20.5K ﹤0.01% 2033
2025
Q2
$86.9K Buy
5,623
+1,003
+22% +$14.8K ﹤0.01% 1828
2025
Q1
$68.8K Buy
4,620
+1,045
+29% +$14.6K ﹤0.01% 1722
2024
Q4
$47.3K Buy
3,575
+1,976
+124% +$27.1K ﹤0.01% 1688
2024
Q3
$22.7K Buy
1,599
+238
+17% +$3.38K ﹤0.01% 2031
2024
Q2
$17.7K Buy
1,361
+325
+31% +$4.3K ﹤0.01% 1821
2024
Q1
$14.2K Sell
1,036
-632
-38% -$9.19K ﹤0.01% 1618
2023
Q4
$23.8K Buy
1,668
+867
+108% +$12.3K ﹤0.01% 1289
2023
Q3
$12.4K Buy
801
+733
+1,078% +$11.3K ﹤0.01% 1223
2023
Q2
$1.07K Hold
68
– – ﹤0.01% 1956
2023
Q1
$1.12K Hold
68
– – ﹤0.01% 1820
2022
Q4
$1.06K Buy
+68
New +$950 ﹤0.01% 1636

Other funds holding TAK

Farther Finance Advisors's TAK Position: Q3 2026 in Review

Farther Finance Advisors increased its Takeda Pharmaceutical (TAK) stake by 19% in Q3 2026, buying an estimated $72.4K and bringing the position to 25,420 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1646.

Farther Finance Advisors first reported a position in TAK in Q4 2022 and has held it in 16 quarters since. 26 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Farther Finance Advisors held 25,420 shares of Takeda Pharmaceutical worth $462K as of Q3 2026.
  • Farther Finance Advisors bought 4,088 Takeda Pharmaceutical shares in Q3 2026, an estimated $72.4K.
  • Takeda Pharmaceutical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1646 holding.
  • Farther Finance Advisors first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
  • 26 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.